-
1
Supplementary Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Gepubliceerd in 2025Onderwerpen: -
2
Supplementary Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Gepubliceerd in 2025Onderwerpen: -
3
Supplementary Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Gepubliceerd in 2025Onderwerpen: -
4
Supplementary Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer
Gepubliceerd in 2025Onderwerpen: -
5
Supplementary Data from Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer
Gepubliceerd in 2025Onderwerpen: -
6
Supplementary Data from Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer
Gepubliceerd in 2025Onderwerpen: -
7
Supplementary Data from Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer
Gepubliceerd in 2025Onderwerpen: -
8
Supplementary Data from Sphingosine Kinase 2 in Stromal Fibroblasts Creates a Hospitable Tumor Microenvironment in Breast Cancer
Gepubliceerd in 2025Onderwerpen: -
9
-
10
-
11
-
12
-
13
Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner
Gepubliceerd in 2025Onderwerpen: -
14
Supplementary Data 3 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms
Gepubliceerd in 2025Onderwerpen: -
15
Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms
Gepubliceerd in 2025Onderwerpen: -
16
Supplementary Data 2 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms
Gepubliceerd in 2025Onderwerpen: -
17
-
18
-
19
-
20